| 000 | 01064 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517120643.0 | ||
| 264 | 0 | _c20170626 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2016.09.055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Di | |
| 245 | 0 | 0 |
_aCyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring N _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _c11 2016 |
||
| 300 |
_a5234-5239 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPeptides, Cyclic _xpharmacology |
| 650 | 0 | 4 |
_aSirtuin 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSirtuin 2 _xantagonists & inhibitors |
| 700 | 1 | _aZheng, Weiping | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 26 _gno. 21 _gp. 5234-5239 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2016.09.055 _zAvailable from publisher's website |
| 999 |
_c26487556 _d26487556 |
||